On Friday, Zoetis Inc (ZTS) stock saw a decline, ending the day at $163.32 which represents a decrease of $-1.70 or -1.03% from the prior close of $165.02. The stock opened at $163.6 and touched a low ...

Investment analysts at Zacks Research cut their FY2025 earnings estimates for Zoetis in a research report issued on Wednesday ...

Shares of Zoetis Inc. ZTS slipped 1.03% to $163.32 Friday, on what proved to be an all-around dismal trading session for the ...

Zoetis's ZTS short percent of float has risen 14.88% since its last report. The company recently reported that it has 6.26 ...

For many investors, the main point of stock picking is to generate higher returns than the overall market. But the ...

Why investors should use the Zacks Earnings ESP tool to help find stocks that are poised to top quarterly earnings estimates.

In a recent “Dear Veterinarian” letter, the FDA alerted veterinarians of adverse events in dogs treated with bedinvetmab ...

The US will rebuild a stockpile of avian influenza vaccines for poultry that match the strain of the virus circulating in ...

Zoetis (ZTS) closed at $165.02 in the latest trading session, marking a +0.94% move from the prior day. The stock exceeded the S&P 500, which registered a gain of 0.16% for the day. Elsewhere, the Dow ...

Not long after Librela's FDA approval, Facebook and other social media groups began forming about serious side effects.

Zoetis Inc. closed $35.51 short of its 52-week high ($200.53), which the company reached on February 29th.

Hyderabad: The queue of global pharma giants wanting to make Hyderabad their new home for drug discovery and tech centres is ...